Next Financial Group’s Myriad Genetics MYGN Stock Holding History

Next Financial Group’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$3K	Sell	100 -100	-50%	-$2.9K	﹤0.01%	2547
2021 Q3	$6K	Hold	200	–	–	﹤0.01%	2203
2021 Q2	$6K	Sell	200 -200	-50%	-$5.78K	﹤0.01%	2151
2021 Q1	$12K	Buy	+400	New	+$11.4K	﹤0.01%	1835
2019 Q3	–	Sell	-26	Closed	-$1K	–	2379
2019 Q2	$1K	Buy	+26	New	+$734	﹤0.01%	2230
2019 Q1	–	Sell	-26	Closed	-$1K	–	1943
2018 Q4	$1K	Sell	26 -74	-74%	-$2.66K	﹤0.01%	1860
2018 Q3	$5K	Buy	+100	New	+$4.45K	﹤0.01%	1162
2016 Q4	–	Sell	-25	Closed	-$1K	–	2444
2016 Q3	$1K	Buy	+25	New	+$634	﹤0.01%	2288
2014 Q4	–	Sell	-100	Closed	-$4K	–	2179
2014 Q3	$4K	Buy	+100	New	+$3.73K	﹤0.01%	2153

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Next Financial Group's MYGN Position: Q4 2021 in Review

Next Financial Group reduced its Myriad Genetics (MYGN) stake by 50% in Q4 2021, selling an estimated $2.9K and leaving 100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

Next Financial Group first reported a position in MYGN in Q3 2014 and has held it in 9 quarters since. The position peaked at $12K in Q1 2021. 197 funds tracked by Wall St. Rank hold MYGN as of Q4 2021.

Next Financial Group held 100 shares of Myriad Genetics worth $3K as of Q4 2021.
Next Financial Group sold 100 Myriad Genetics shares in Q4 2021, an estimated $2.9K.
Myriad Genetics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2547 holding.
Next Financial Group first reported a position in Myriad Genetics in Q3 2014 and has held it in 9 quarters since.
Next Financial Group's Myriad Genetics position peaked at $12K in Q1 2021.
197 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.